Browsing by Sponsor/Funder Novartis Pharmaceuticals UK Limited
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) |
|---|---|---|
| 1-Nov-2017 | IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer | Palmieri, C; Szydlo, R; Miller, M; Barker, L; Patel, NH, et al |
| 13-Jun-2017 | IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients | Palmieri, C; Stein, RC; Liu, X; Hudson, E; Nicholas, H, et al |
| 22-Jul-2015 | Modeling in vivo interactions of engineered nanoparticles in the pulmonary alveolar lining fluid | Mukherjee, D; Porter, A; Ryan, M; Schwander, S; Chung, KF, et al |
| 16-Aug-2017 | p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells | Periyasamy, M; Singh, A; Gemma, C; Kranjec, C; Farzan, R, et al |
| 30-Nov-2018 | The argument for using imatinib in CML | Claudiani, S; Apperley, JF; , et al |